Skip to content
★ Sign in to follow
CT

CARGO Therapeutics, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Samsara BioCapital GP, LLC, was filed 03 Jun 2024.

Insider Decl.
26
Thresholds
n/a
Buy Volume
€37M
4 ops. · all time
Sell Volume
€370,697
6 ops. · all time

CARGO Therapeutics, Inc.: what insiders have been doing

Every trade that managers of CARGO Therapeutics, Inc. disclose to SEC (Form 4) is tracked on this page. CARGO Therapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 19 August 2025.

Looking back to 2023, when coverage begins, insiders filed 4 purchases and 6 sales.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Who traded when

BuySale
Anup Radhakrishnan3 sales

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2024

FY ended December 2024 · cache

Income statement
Net income-149.1M
Last declaration on 19 August 2025

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations26 total
  • ●
    See RemarksExecutives
    277,850 USD6SEC
    63,436 shares@ US$4.3839.6% of flowCommon StockSEC:0001610717-25-000297:1
  • ●
    See RemarksExecutives
    251,114 USD9SEC
    57,345 shares@ US$4.37965.6% of flowCommon StockSEC:0001610717-25-000297:0
  • ▼
    See RemarksExecutives
    6,822 USD2SEC
    1,632 shares@ US$4.181.8% of flowCommon StockSEC:0001610717-25-000275:0
  • ▼
    See RemarksExecutives
    105,272 USD5SEC
    27,404 shares@ US$3.841528.7% of flowCommon StockSEC:0001610717-25-000121:0
  • ◆
    See RemarksExecutives
    0SEC
    72,500 shares0Common StockSEC:0001610717-25-000119:0
  • ▼
    See RemarksExecutives
    6,522 USD2SEC
    1,629 shares@ US$4.00371.8% of flowCommon StockSEC:0001610717-25-000096:0
  • ◆
    President & CEOExecutives
    0SEC
    200,000 shares0Common StockSEC:0001610717-25-000069:0
  • ◆
    See RemarksExecutives
    0SEC
    72,500 shares0Common StockSEC:0001610717-25-000071:0
  • ◆
    Chief Technical OfficerExecutives
    0SEC
    60,000 shares0Common StockSEC:0001610717-25-000068:0
  • ◆
    Chief Medical OfficerExecutives
    0SEC
    50,000 shares0Common StockSEC:0001610717-25-000070:0
  • ▼
    Chief Financial OfficerExecutives
    40,448 USD32SEC
    1,600 shares@ US$25.286.0% of flowCommon StockSEC:0001610717-24-000491:1
  • ▼
    President & CEOExecutives
    179,795 USD40SEC
    7,166 shares@ US$25.0959.0% of flowCommon StockSEC:0001610717-24-000492:1
  • ◇
    President & CEOExecutives
    14,964 USD22SEC
    2,975 shares@ US$5.034.9% of flowCommon StockSEC:0001610717-24-000492:2
  • ▼
    President & CEOExecutives
    74,464 USD36SEC
    2,975 shares@ US$25.0324.3% of flowCommon StockSEC:0001610717-24-000492:3
  • ◇
    President & CEOExecutives
    36,045 USD30SEC
    7,166 shares@ US$5.03100.0% of flowCommon StockSEC:0001610717-24-000492:0
  • ◇
    Chief Financial OfficerExecutives
    8,048 USD19SEC
    1,600 shares@ US$5.032.2% of flowCommon StockSEC:0001610717-24-000491:0
  • ▲
    Related company / holdingExecutives
    5M USD10SEC
    294,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001415889-24-015250:0
    Canonical exit: 28 Aug 2024 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    1,842,499 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0000902664-24-000237:0
  • ▲
    Related company / holdingExecutives
    10M USD27SEC
    666,666 shares@ US$15.0067.0% of flowCommon StockSEC:0001209191-23-055621:1
    Canonical exit: 12 Feb 2024 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    3,381,323 sharesCommon StockSEC:0001209191-23-055621:0
  • ●
    Related company / holdingExecutives
    0SEC
    737,000 sharesCommon StockSEC:0000950170-23-064519:0
  • ●
    Related company / holdingExecutives
    0SEC
    473,786 sharesCommon StockSEC:0000899243-23-020350:1
  • ▲
    Related company / holdingExecutives
    5M USD19SEC
    333,333 shares@ US$15.0050.0% of flowCommon StockSEC:0001062993-23-020811:1
    Canonical exit: 12 Feb 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    20M USD25SEC
    1,333,333 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-020350:2
    Canonical exit: 12 Feb 2024 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    2,579,502 sharesCommon StockSEC:0001062993-23-020811:0

25 of 26 declarations

About CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It specializes in utilizing T cell technology to target tumors.

Written on 25 June 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.